NeoGenomics Appoints President, COO Warren Stone As CEO, Effective Jan, 4 Next Year, Succeeding Tony Zook; Zook Appointed Executive Chair, Succeeding Lynn Tetrault
NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that as part of a planned succession,
Share
Why It Matters
NeoGenomics is switching leaders as part of a planned plan. The new CEO was already running day to day work.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.